248 related articles for article (PubMed ID: 4644653)
21. Drug interaction.
Gralla EJ
Vet Clin North Am; 1975 Nov; 5(4):717-26. PubMed ID: 242109
[No Abstract] [Full Text] [Related]
22. The developability classification system: application of biopharmaceutics concepts to formulation development.
Butler JM; Dressman JB
J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390
[TBL] [Abstract][Full Text] [Related]
23. Does the Intake of Ethanol Affect Oral Absorption of Poorly Soluble Drugs?
Keemink J; Sjögren E; Holm R; Bergström CAS
J Pharm Sci; 2019 May; 108(5):1765-1771. PubMed ID: 30562491
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal absorption. I. Mechanisms.
Blanchard J
Am J Pharm Sci Support Public Health; 1975; 147(5):135-46. PubMed ID: 3972
[No Abstract] [Full Text] [Related]
25. Refresher courses in pharmacology. II. The absorption of drugs.
Jenkins WL
J S Afr Vet Med Assoc; 1971 Mar; 42(1):3-7. PubMed ID: 5161393
[No Abstract] [Full Text] [Related]
26. Effect of route of administration on drug disposition.
Riegelman S; Rowland M
J Pharmacokinet Biopharm; 1973 Oct; 1(5):419-34. PubMed ID: 4787618
[No Abstract] [Full Text] [Related]
27. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
28. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and temperature.
Ballard BE
J Pharm Sci; 1974 Sep; 63(9):1345-58. PubMed ID: 4610118
[No Abstract] [Full Text] [Related]
30. Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs.
Raman S; Polli JE
Int J Pharm; 2016 Jun; 506(1-2):110-5. PubMed ID: 27067239
[TBL] [Abstract][Full Text] [Related]
31. Transfer functions obtained by the rule of corresponding fractional areas.
Dost FH; von Hattingberg HM
Eur J Clin Pharmacol; 1971 Sep; 3(4):252-4. PubMed ID: 5151310
[No Abstract] [Full Text] [Related]
32. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
34. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
[No Abstract] [Full Text] [Related]
35. Mixing-tank model for predicting dissolution rate control or oral absorption.
Dressman JB; Fleisher D
J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
[TBL] [Abstract][Full Text] [Related]
36. Role of surface-active agents in drug absorption.
Gibaldi M
Fed Proc; 1970; 29(4):1343-9. PubMed ID: 4990014
[No Abstract] [Full Text] [Related]
37. Gordon L. Amidon: Very Sustained Drug Absorption.
Donovan MD; Polli JE; Langguth P; Tamai I; Vig B; Yu LX
J Pharm Sci; 2015 Sep; 104(9):2650-63. PubMed ID: 26053319
[No Abstract] [Full Text] [Related]
38. Perspective on improving passive human intestinal absorption.
Yalkowsky SH
J Pharm Sci; 2012 Sep; 101(9):3047-50. PubMed ID: 22374839
[TBL] [Abstract][Full Text] [Related]
39. Formulation and absorption of drugs.
Lancet; 1968 Jan; 1(7533):79. PubMed ID: 4169126
[No Abstract] [Full Text] [Related]
40. Paediatric oral biopharmaceutics: key considerations and current challenges.
Batchelor HK; Fotaki N; Klein S
Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
